207940.KS Stock — Price, Charts & Analysis

Samsung Biologics Co.,Ltd. (207940.KS) has no trailing P/E shown and a forward P/E of 31.45x. This places 207940.KS in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

207940.KS trades with 31.45x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether 207940.KS looks overvalued or undervalued.

207940.KS's P/E of 31.45x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

207940.KS's trailing EPS is not shown and forward EPS is ₩41,224.97. Reported earnings growth is 25.10%, which helps show current profit momentum.

Samsung Biologics Co.,Ltd. has a market cap of ₩71.8T, making 207940.KS a large-cap stock based on the current market value shown on Worldtickers.

207940.KS's latest stock price on Worldtickers is ₩1,551,000.00. The latest move is -₩23,000.00 or -1.46%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

207940.KS's quote includes a latest price of ₩1,551,000.00. The market open is ₩1,539,000.00. Previous close is ₩1,574,000.00. The intraday range is ₩1,530,000.00 to ₩1,564,000.00.

207940.KS is down in the latest quote, with a move of -₩23,000.00 or -1.46%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

207940.KS generated ₩4.81T in trailing revenue. Revenue growth is 25.80%, which helps show whether demand is expanding or slowing.

207940.KS's revenue growth is 25.80%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, 207940.KS shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is ₩1.75T.

Gross margin is 54.86%. Margins show how efficiently Samsung Biologics Co.,Ltd. turns revenue into profit.

Samsung Biologics Co.,Ltd. carries ₩1.19T and holds ₩1.65T in cash.

207940.KS holds ₩1.65T on its balance sheet.

Institutions hold 16.41% of 207940.KS shares. Insiders hold 74.37% of shares. Ownership mix helps investors understand how much of Samsung Biologics Co.,Ltd. is held by professional investors and company insiders.

207940.KS has 46.29M shares outstanding. Float shares are 11.8M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for 207940.KS, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for 207940.KS is ₩41,224.97. Earnings growth is 25.10%. Revenue growth is 25.80%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

207940.KS is in the Healthcare sector. Its earnings multiple is 31.45x. Its latest displayed growth metric is 25.80%. Compare these figures with sector peers before deciding whether Samsung Biologics Co.,Ltd. is stronger or weaker than average.

207940.KS trades at ₩1,551,000.00. The stock trades at 31.45x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Samsung Biologics Co.,Ltd.'s fundamentals.

207940.KS risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.21, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

207940.KS should be compared with companies in Biotechnology. Its earnings multiple is 31.45x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Samsung Biologics Co.,Ltd. (207940.KS) operates in Healthcare, specifically Biotechnology. Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, cold chain storage and shipping, and regulatory support services; and qual

207940.KS trades on KSE. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

207940.KS stock is priced in KRW on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Samsung Biologics Co.,Ltd.'s official website listed on Worldtickers is samsungbiologics.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Samsung Biologics Co.,Ltd. employs about 5.2K people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Samsung Biologics Co.,Ltd. is headquartered in Incheon, South Korea. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

207940.KS is in the Healthcare sector and the Biotechnology industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

207940.KS has traded between ₩1,228,000.00 and ₩1,987,000.00 over the past 52 weeks. At ₩1,551,000.00, it is 21.94% below the high and 26.30% above the low. The 52-week range helps gauge long-term price momentum.

207940.KS is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. Its 50-day moving average is ₩1,429,220.00 and its 200-day moving average is ₩1,599,731.05.

207940.KS's RSI is 58.88. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

207940.KS's latest RSI reading is 58.88, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for 207940.KS is near ₩1,360,000.00. Key resistance is near ₩1,628,000.00. Breaks above resistance or below support can change the short-term technical setup.

207940.KS's nearest reported support level is ₩1,360,000.00. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

207940.KS's nearest reported resistance level is ₩1,628,000.00. A breakout above resistance can improve momentum, especially when volume confirms the move.

207940.KS trades about 63.14K shares daily on average. The latest displayed volume is 44.7K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

207940.KS's MACD is -33.25, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

207940.KS is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. RSI is 58.88 (neutral). MACD is bearish. Nearest support is around ₩1,360,000.00. Resistance is around ₩1,628,000.00. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is ₩1,521,500.00 (3.45% from price). MA50 is ₩1,429,220.00 (10.13% from price). MA200 is ₩1,599,731.05 (-1.61% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. 207940.KS's MA20 is ₩1,521,500.00. MA50 is ₩1,429,220.00. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

207940.KS's pivot is near ₩1,524,666.67. Support is near ₩1,360,000.00. Resistance is near ₩1,628,000.00. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for 207940.KS is near ₩1,499,500.00. The next upper resistance zone is near ₩1,639,428.57. These levels help define risk and possible follow-through zones after a breakout or breakdown.

207940.KS's Bollinger range is roughly ₩1,416,357.24 to ₩1,626,642.76. Band width is near 13.82%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

207940.KS's ATR-based typical daily range is about 4.17%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 44.7K shares. Average volume is about 63.14K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

207940.KS's all-time high shown on Worldtickers is ₩1,987,000.00. Its all-time low is ₩211,472.72. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

207940.KS has a beta of 0.21, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.